Polycore Therapeutics

Developer of therapeutics to treat central nervous system disorders

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2014 groups3 employees language polycoretherapeutics.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 12 times.

YearFilings
20201
20211
20221

Investor mix

3 investors on record; lead investors include Ben Franklin Technology Partners, Xontogeny.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%
Coming soon